Search clinical trials for: Humira (adalimumab-EU)

Total 820 results

Gilead Sciences
Galapagos NV

Completed

Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate (FINCH 1)

Rheumatoid Arthritis

United States, Italy, Poland, Ukraine, Belgium, Hong Kong, Taiwan, Spain, Israel, Bulgaria, India, Serbia, South Africa, Korea, Republic of, Japan, Russian Federation, Argentina, Germany, New Zealand, Thailand, Hungary, Netherlands, Slovaki... and more
Samsung Bioepis Co., Ltd.

Completed

Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male Subjects

Healthy

Germany
AbbVie (prior sponsor, Abbott)

Completed

A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) (MUSICA)

Rheumatoid Arthritis

United States, Puerto Rico
Zhongshan Ophthalmic Center, Sun Yat-sen University
The First Affiliated Hospital of Soochow University; Shandong Eye Hospital; Shenzhen... and other collaborators

Recruiting

Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis

Uveitis

China
Biogen

Completed

A Real-world Study of Imraldi® Use (PROPER)

Arthritis, Rheumatoid (RA) | Arthritis, Psoriatic (PsA) | Crohn's Disease (CD) | Colitis, Ulcerative (UC) | Axial Spondyloarthritis (axSpA)

Italy, United Kingdom, Germany, Belgium, Spain, Ireland
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis

AS
Huons Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of Humia Inj. in Patients With Symptomatic Osteoarthritis of the Knee

Osteoarthritis of Knee

Korea, Republic of
Celltrion

Not yet recruiting

A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis
Alteogen, Inc.
Cristália Produtos Químicos Farmacêuticos Ltda.

Completed

A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects

Healthy
Oslo University Hospital

Completed

Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease

Norway
Abbott
Eisai Limited

Completed

Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis

Japan
Momenta Pharmaceuticals, Inc.

Completed

Assessment of Pharmacokinetics and Safety of M923 Administered Via Auto-injector or Prefilled Syringe, in Healthy Subjects

Healthy

United States, United Kingdom
Fundació Institut de Recerca de l'Hospital de la...

Completed

Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab

Arthritis,Rheumatoid

Spain
Glostrup University Hospital, Copenhagen

Completed

Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers

Rheumatoid Arthritis

Denmark
Glostrup University Hospital, Copenhagen
Abbott

Unknown

Danish Multicenter Study of Adalimumab in Spondyloarthritis (DANISH)

Spondyloarthritis

Denmark
Abbott

Completed

A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)

Psoriatic Arthritis
GlaxoSmithKline

Completed

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.

Psoriasis

United Kingdom
Enzene Biosciences Ltd.
Alkem Laboratories Ltd

Recruiting

Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers

Healthy Male Subjects

Bulgaria, Poland
Shanghai Henlius Biotech

Completed

Compare Pharmacokinetics, Safety, and Immunogenicity of HLX11 vs. Perjeta in Healthy Chinese Male Subjects

Healthy Male Volunteers

China
Pronova BioPharma

Completed

Bioavailability of Omega-3 Food Supplement in Healthy Subjects

Biological Availability

United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis (EXCEED 1)

Psoriatic Arthritis

Spain, United Kingdom, Estonia, Hungary, India, Italy, Germany, Israel, United States, Australia, Greece, Bulgaria, Lithuania, Korea, Republic of, Portugal, Russian Federation, Netherlands, France, Czechia, Canada, Poland, Slovakia, Denmar... and more
Momenta Pharmaceuticals, Inc.

Completed

Usability of an AI for M923 in Subjects With Moderate to Severe RA

Rheumatoid Arthritis

United States
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers

Healthy
Rigshospitalet, Denmark

Completed

Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis (ASIM)

Spondyloarthritis

Denmark
Meiji Seika Pharma Co., Ltd.

Completed

A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects (DMB-3113-1)

Healthy Volunteer

Japan
Mylan Pharmaceuticals Inc
Mylan GmbH

Completed

Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion

Healthy
Ente Ospedaliero Ospedali Galliera

Active, not recruiting

Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)

Iron Overload | Neurodegenerative Disease

Italy
Xentria, Inc.

Recruiting

Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia®

Healthy Participants

Netherlands, Hungary
Luye Pharma Group Ltd.
Parexel

Completed

A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous Injection

Healthy

Germany
mAbxience Research S.L.

Completed

Pharmacokinetic Study Comparing MB05 (Proposed Palivizumab Biosimilar), EU-sourced Synagis® and US-sourced Synagis® in Healthy Volunteers.

Healthy Volunteers

Australia, New Zealand
Shanghai Henlius Biotech

Completed

A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects

Healthy

China
Bristol-Myers Squibb

Completed

Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Canada, Mexico
University Hospital Southampton NHS Foundation...
Imperial College London; Public Health England

Completed

Safety of Nasal Influenza Immunisation in Egg Allergic Children (SNIFFLE)

Egg Hypersensitivity

United Kingdom
Leiden University Medical Center
Galapagos NV

Not yet recruiting

Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis (JAKAR)

Rheumatoid Arthritis

Netherlands
University Hospital, Gentofte, Copenhagen
Pfizer; The Michaelsen Foundation

Unknown

TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis

Psoriasis

Denmark, Sweden
University of Rochester

Completed

Aromatherapy for Integrated Cancer Care

Cancer

United States
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Sciences Po Paris

Completed

Comparison of Characteristics of Bronchoalveolar Lavage Dusting and of Specific Questionnary Data in Healthy Volunteers and Patients Suffering From Sarcoidosis (MINASARC01)

Sarcoidosis
William Beaumont Hospitals

Completed

Impact of Humeral Component Version on Outcomes Following RTSA

Rotator Cuff Tear Arthropathy

United States
University Hospital, Ghent
KU Leuven

Completed

A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated

Psoriasis

Belgium
Ludwig-Maximilians - University of Munich

Completed

Acute Application of Pegvisomant and Octreotide in Acromegaly

Acromegaly

Germany
Genzyme, a Sanofi Company
Bioenvision

Completed

A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia

Acute Lymphoblastic Leukemia

France, Germany, United Kingdom, Netherlands, Italy, Austria
NorthShore University HealthSystem
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Effects of TNF Blockade on Human BPH/LUTS

Benign Prostatic Hyperplasia (BPH)

United States
Tianjin Medical University

Recruiting

A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

Vogt-Koyanagi-Harada Disease | Adalimumab

China
Abbott

Completed

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

Crohn's Disease

United States, Canada, Belgium, France
Vissum, Instituto Oftalmológico de Alicante
AkkoLens Clinical bv

Completed

Efficacy of the AkkoLens IOL in Patients With Cataract

Cataract
Boston College
Grand Challenges Canada; InfaCare Pharmaceuticals Corporation, a Mallinckrodt... and other collaborators

Active, not recruiting

The Sugira Muryango PLAY Collaborative

Parent-Child Relations | Parenting | Child Development | Child Malnutrition

Rwanda
Boston College

Completed

Strong Families, Thriving Children "Sugira Muryango"_Activity C

Child Development, Social Protection

Rwanda
Supira Medical

Not yet recruiting

Early Feasibility Study of the Supira System in Patients Undergoing HRPCI (SUPPORT1)

Ventricular Assist Device
Supira Medical

Not yet recruiting

Feasibility Study SA of the Supira System for HRPCI

Heart Diseases | Heart Failure
Consorci Sanitari de Terrassa

Completed

Retrovertion Assesment and Study in Elderly Patients With Reverse Total Shoulder Arthroplasty

Rotator Cuff Tears | Rotator Cuff Tear Arthropathy

Spain

Search clinical trials for: Humira (adalimumab-EU)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations